Last Update Time:
18-Mar-2025 16:00:00
ISIN:
INE804L01022
Sector:
Consumer Services
Symbol:
MEDPLUS
Medplus Health Services Limited
₹693.50
₹-6.50
(-0.93%)
▼
Prev. Close
₹700.00
Open
₹700.00
Close
₹694.50
Range
₹658.83 - ₹728.18
High
₹703.55
Low
₹688.50
Ind. Close
₹0.00
VWAP
₹695.34
The current stock price of Medplus Health Services Limited is ₹693.50, with a target price range between ₹658.83 and ₹728.18. The stock has experienced a price change of ₹-6.50 (-0.93%), reflecting recent market volatility.
Today's opening price was ₹700.00, while the previous close stood at ₹700.00.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Medplus Health Services Limited Price Chart
Medplus Health Services Limited Pre Open Market Overview: 18-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 700
- Previous Close Price: 700
- Change: 0.00%
- Total Traded Volume: 42
- Total Buy Quantity: 3,018
- Total Sell Quantity: 5,868
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 691.30 | 200.00 | 0.00 |
| 693.60 | 44.00 | 0.00 |
| 694.00 | 10.00 | 0.00 |
| 695.05 | 50.00 | 0.00 |
| 700.00 | 44.00 | 0.00 |
| 703.70 | 0.00 | 44.00 |
| 706.95 | 0.00 | 7.00 |
| 709.80 | 0.00 | 100.00 |
| 715.00 | 0.00 | 37.00 |
| 715.60 | 0.00 | 1.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 3018
Total Sell Quantity: 5868
Shareholding Patterns of Medplus Health Services Limited
Key Trade Statistics of Medplus Health Services Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.82 |
| Traded Value (₹ Cr.) | 5.71 |
| Total Market Cap (₹ Cr.) | 8,300.77 |
| Free Float Market Cap (₹ Cr.) | 4,464.33 |
| Impact cost | 0.06 |
| Quantity Traded | 82,105.00 |
| Deliverable Quantity | 37,402.00 |
| % of Quantity to Traded | 45.55 |
| Security VaR | 11.96 |
| Index VaR | N/A |
| VaR Margin | 11.96 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 15.46 |
| Face Value | 2 |
Key Price Statistics of Medplus Health Services Limited
The 52-week high for Medplus Health Services Limited was ₹875.65, recorded on 06-Dec-2024. On the other hand, the 52-week low stands at ₹616.00, with the lowest value recorded on 26-Aug-2024.
The upper band for trading is ₹840.00, and the lower band is ₹560.00. The price band is 20%.
The stock's daily volatility stands at 1.88, while the annualized volatility is 35.92. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (06-Dec-2024) | 875.65 |
| 52 Week Low (26-Aug-2024) | 616.00 |
| Upper Band | 840.00 |
| Lower Band | 560.00 |
| Price Band (%) | 20 |
| Daily Volatility | 1.88 |
| Annualised Volatility | 35.92 |
| Tick Size | 0.05 |
Key Securities Statistics of Medplus Health Services Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 23-Dec-2021 |
| Adjusted P/E | 63.25 |
| Symbol P/E | 63.25 |
| Index | NIFTY TOTAL MARKET |
| Macro-Economic Sector | Consumer Discretionary |
| Sector | Consumer Services |
| Industry | Retailing |
| Basic Industry | Pharmacy Retail |
Security Status of Medplus Health Services Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Medplus Health Services Limited
| Subject | Date |
|---|---|
| Change in Director(s) | 13-Mar-2025 |
| Shareholders meeting | 13-Mar-2025 |
| Shareholders meeting | 13-Mar-2025 |
| General Updates | 13-Mar-2025 |
| General Updates | 12-Mar-2025 |
| General Updates | 11-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 10-Mar-2025 |
| General Updates | 07-Mar-2025 |
Corporate Actions of Medplus Health Services Limited
| Face Value | Purpose | Ex-Date | ||
|---|---|---|---|---|
| No corporate actions available | ||||
Board Meetings of Medplus Health Services Limited
Financial Results of Medplus Health Services Limited
Company Directory of Medplus Health Services Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | H No 11 5 56 Survey No 257 and 258 1, Opp IDPL Railway siding Moosapet kukatpally |
HYDERABAD |
| N/A | Registered Office | H.NO. 11-6-56, Sy. NO. 257& 258/1 Opp: IDPL Railway Siding Road Moosapet, kukatpally |
HYDERABAD |
| N/A | Transfer Agent | Selenium Tower B Plot No 31 and 32 Financial District Nanakramguda Serilingampally |
HYDERABAD |
Insider Trading of Medplus Health Services Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Lone Furrow Investment Private Limited | 415875000 | Pledge |
| 7(2) | MADHUKAR REDDY GANGADI | 1624918586 | Pledge |
| 7(2) | Lone Furrow Investment Private Limited | 12885619852 | Pledge Revoke |
| 7(2) | MADHUKAR REDDY GANGADI | 11629111554 | Pledge |
| 7(2) | AGILEMED INVESTMENTS PRIVATE LIMITED | 218315533 | Pledge |
| 7(2) | Lone Furrow Investments Private Limited | 362097940 | Pledge |
| 7(2) | AGILEMED INVESTMENTS PRIVATE LIMITED | 136500480 | Pledge |
| 7(2) | Lone Furrow Investments Private Limited | 275741712 | Pledge |
| 7(2) | Lone Furrow Investments Private Limited | 896980000 | Pledge |
| 7(2) | AGILEMED INVESTMENTS PRIVATE LIMITED | 295895917 | Pledge |
| 7(2) | AGILEMED INVESTMENTS PRIVATE LIMITED | 16727594 | Pledge |
| 7(2) | AGILEMED INVESTMENTS PRIVATE LIMITED | 287901180 | Pledge |
| 7(2) | AGILEMED INVESTMENTS PRIVATE LIMITED | 8459568106 | Pledge |
| 7(2) | MADHUKAR GANGADI REDDY | 3675732597 | Pledge |
| 7(2) | AGILEMED INVESTMENTS PRIVATE LIMITED | 1327733333 | Pledge |
| 7(2) | Lone Furrow Investments Private Limited | 6749634 | Buy |
| 7(2) | Lone Furrow Investments Private Limited | 3502275 | Buy |
| 7(2) | MADHUKAR GANGADI REDDY | 1393364838 | Pledge |
| 7(3) | Madhavan Ganesan | 5500000 | Buy |
Annual Reports of Medplus Health Services Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| Medplus Health Services Limited | 2023 | 2024 | |
| Medplus Health Services Limited | 2022 | 2023 | |
| Medplus Health Services Limited | 2021 | 2022 |
Investor Complaints of Medplus Health Services Limited
Event Calendar of Medplus Health Services Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Medplus Health Services Limited has informed the Exchange about Board Meeting to be held on 10-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Medplus Health Services Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2022 to consider financial statements for the period ended September 2022. |
| Financial Results | To consider and approve the financial results for the quarter and nine months ended December 31, 2022. |
| Other business matters | The Company has informed the exchange regarding Board Meeting scheduled on 11th May, 2023 to consider for approval of Members through Postal Ballot for the 2 business matters |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Financial Results | MEDPLUS : 07-Aug-2023 : The Company has informed the Exchange that a Board meeting to be held on August 01, 2023 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 07, 2023, to consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 to consider and approve the un-audited Financial Results of the Company for the quarter ended June 30, 2023. |
| Fund Raising | Prior intimation pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended |
| Fund Raising | Prior intimation pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
| Financial Results/Fund Raising | Board Meeting Intimation for approval of un-audited Financial Results And Consideration And Approval Of The Notice for calling Extraordinary General Meeting / Postal Ballot Notice To Obtain approval of Members For Raising Of Funds |
| Financial Results | Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. |
| Financial Results | The Company has informed the Exchange that a Board meeting to be held on October 26, 2023 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 08, 2023, To consider and approve the Un-audited financial results for the period ended September 30, 2023 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
| Other business matters | To discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2024 |
| Financial Results | To consider and approve the Un-audited Standalone andConsolidated Financial Results of the Company for the quarter ended June 30, 2024 and Trading Window Closure under SEBI (Prohibition of Insider Trading)Regulations, 2015 |
| Financial Results | Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to consider and approve un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended September 30, 2024 |
| Financial Results | Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 |
Share Transfers of Medplus Health Services Limited
| Company | Period | Reg.7 | Reg.40 |
|---|---|---|---|
| Medplus Health Services Limited | 31-MAR-2024 | ||
| Medplus Health Services Limited | 31-MAR-2023 | ||
| Medplus Health Services Limited | 31-MAR-2022 |
Voting Results of Medplus Health Services Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 13-MAR-2025 | Postal Ballot | Appointment of Mr. Thyagarajan Muralidharan (DIN: 00052097), as a Non-Executive Independent Director of the Company |
| 12-MAR-2025 | Postal Ballot | Appointment of Mr. Thyagarajan Muralidharan (DIN: 00052097), as a Non-Executive Independent Director of the Company |
| 12-MAR-2025 | Postal Ballot | Appointment of Mr. Thyagarajan Muralidharan (DIN: 00052097), as a Non-Executive Independent Director of the Company |
| 12-MAR-2025 | Postal Ballot | Appointment of Mr. Thyagarajan Muralidharan (DIN: 00052097), as a Non-Executive Independent Director of the Company |
| 12-MAR-2025 | Postal Ballot | Appointment of Mr. Thyagarajan Muralidharan (DIN: 00052097), as a Non-Executive Independent Director of the Company |
| 26-SEP-2024 | AGM | To receive, consider and adopt Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2024, and the Reports of Board of Directors and Auditors thereon |
| 26-SEP-2024 | AGM | Ratification fo remuneration to M/s. M P R & Associates, Cost Accountants (Firm Registration No.:000413, Cost Auditors of the Company for the Financial Year 2023-24 |
| 26-SEP-2024 | AGM | Appointment of Ms. Aparna Surabhi (DIN:01641633) as Non-Executive Independent Director of the Company |
| 15-DEC-2023 | Court Convened Meeting | To consider and approve the Scheme of Amalgamation of MHS Pharmaceuticals Private Limited (￢ﾀﾜTransferor Company￢ﾀﾝ) with MedPlus Health Services Limited (￢ﾀﾜTransferee Company/Company￢ﾀﾝ) and their respective shareholders and creditors. |
| 30-NOV-2023 | Postal Ballot | To consider and approve raising of funds and issuance of securities through Qualified Institutions Placement basis or through any other permissible mode |
| 30-NOV-2023 | Postal Ballot | Appointment of Dr. Cherukupalli Bhaskar Reddy (DIN: 00926550) as a Whole-Time Director of the Company |
| 29-SEP-2023 | AGM | To adopt Audited Standalone & Consolidated Financial Statements for FY 2022-23. |
| 29-SEP-2023 | AGM | Alteration in Articles of Association ￢ﾀﾓ insertion of Article 102 A for Nomination Rights of Promoters |
| 29-SEP-2023 | AGM | Appointment of BSR and Co., Chartered Accountants as Statutory Auditors |
| 18-JUN-2023 | Postal Ballot | Extending benefits of Employee Stock Option Plan 2021 to the employees of Subsidiary Company(ies) |
| 18-JUN-2023 | Postal Ballot | Alteration of Articles of Association of the Company - insertion of new Article 102-D |
| 18-JUN-2023 | Postal Ballot | Alteration of Articles of Association of the Company - insertion of new Article 102-C |
| 18-JUN-2023 | Postal Ballot | Alteration of Articles of Association of the Company - insertion of new Article 102-B |
| 18-JUN-2023 | Postal Ballot | Alteration of Articles of Association of the Company - insertion of new Article 102-A |
| 26-SEP-2022 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the Financial Year ended 31st March 2022 and the Reports of the Board of Directors and Auditors thereon |
FAQs on Medplus Health Services Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.